Allergan plc Ordinary Shares (AGN) reported quarterly earnings results on Tuesday, May-10-2016. The company said it had a profit of $3.04 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.03. Analysts had a consensus of $3.01. The company posted revenue of $3796.00 million in the period, compared to analysts expectations of $3949.70 million. The company’s revenue was up 48.1% compared to the same quarter last year.
Many Wall Street Analysts have commented on Allergan plc Ordinary Shares. Shares were Downgraded by Piper Jaffray on Apr 18, 2016 to ” Neutral” and Lowered the Price Target to $ 238 from a previous price target of $311 .Allergan plc Ordinary Shares was Initiated by Guggenheim to “Neutral” on Apr 18, 2016. Goldman Resumed Allergan plc Ordinary Shares on Apr 18, 2016 to “Buy”, Price Target of the shares are set at $275.
Allergan plc Ordinary Shares closed down -8.69 points or -4.13% at $201.65 with 1,28,08,590 shares getting traded on Friday. Post opening the session at $208.98, the shares hit an intraday low of $195.5 and an intraday high of $209.08 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on Dec 9, 2015, Nesli Basgoz (director) sold 2,300 shares at $312.96 per share price. According to the SEC, on Aug 24, 2015, Brent L Saunders (CEO) purchased 1,000 shares at $301.94 per share price. On Aug 24, 2015, Paul Bisaro (Exec Chairman) purchased 1,000 shares at $297.42 per share price, according to the Form-4 filing with the securities and exchange commission.